Łukasz Pawliński

Consensus guideline for the diagnosis and management of mannose phosphate isomerase‐congenital disorder of glycosylation

E. Martins, A. Harroche, P. Witters, 2020, Journal of inherited metabolic disease.

Is treatment of type 1 diabetes mellitus (insulin therapy, metabolic control) optimal for preventing cardiovascular autonomic neuropathy?

B. Matejko, B. Kieć-Wilk, Łukasz Pawliński, 2019 .

Neurological symptoms in hospitalised patients with COVID-19 and their association with in-hospital mortality.

M. Małecki, B. Kaminska, A. Słowik, 2021, Neurologia i neurochirurgia polska.

Gene expression with corresponding pathways analysis in Gaucher disease.

M. Ruchała, B. Kieć-Wilk, A. Polus, 2021, Experimental and molecular pathology.

Proteomic biomarkers in Gaucher disease

B. Kieć-Wilk, M. Suski, A. Polus, 2020, Journal of Clinical Pathology.

Epigenetic mechanism in search for the pathomechanism of diabetic neuropathy development in diabetes mellitus type 1 (T1DM)

P. Kapusta, P. Wołkow, A. Polus, 2020, Endocrine.

MiRNA Expression in Patients with Gaucher Disease Treated with Enzyme Replacement Therapy

B. Kieć-Wilk, A. Polus, B. Solnica, 2020, Life.

Is our treatment in type 1 diabetes mellitus (insulin therapy models, metabolic control) optimal for preventing cardiovascular autonomic neuropathy?

B. Matejko, B. Kieć-Wilk, Łukasz Pawliński, 2019, Endokrynologia Polska.